Page last updated: 2024-12-11

3',4',5'-O-trimethyltricetin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3',4',5'-O-trimethyltricetin : A trimethoxyflavone that is the 3',4',5'-tri-O-methyl ether of tricetin. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5379265
CHEMBL ID486590
CHEBI ID543745
SCHEMBL ID4918477

Synonyms (45)

Synonym
nsc-123410
4h-1-benzopyran-4-one,7-dihydroxy-2-(3,4,5-trimethoxyphenyl)-
5,4',5'-trimethoxyflavone
nsc123410
mls002707300 ,
5,4',5'-trimethoxy flavone
flavone,7-dihydroxy-3',4',5'-trimethoxy-
18103-42-9
5,7-dihydroxy-2-(3,4,5-trimethoxyphenyl)-4h-chromen-4-one
4h-1-benzopyran-4-one, 5,7-dihydroxy-2-(3,4,5-trimethoxyphenyl)-
flavone, 5,7-dihydroxy-3',4',5'-trimethoxy-
5,7-dihydroxy-2-(3,4,5-trimethoxyphenyl)chromen-4-one
5,7-dihydroxy-3',4',5'-trimethoxy flavone
5, 7-dihydroxy-3',4',5'-trimethoxyflavone
5,7-dihydroxy-3',4',5'-trimethoxyflavon
smr001574694
CHEMBL486590
5,7-dihydroxy-2-(3,4,5-trimethoxyphenyl)-4h-1-benzopyran-4-one
tricetin 3',4',5'-trimethyl ether
3',4',5'-o-trimethyltricetin
5,7-dihydroxy-2-(3,4,5-trimethoxyphenyl)-4-benzopyrone
CHEBI:543745 ,
5,7-dihydroxy-3',4',5'-trimethoxyflavone
LMPK12110880
2j9jj5n2h7 ,
nsc 123410
tricin 4'-methyl ether
einecs 242-001-0
unii-2j9jj5n2h7
C19807
mfcd00016924
SCHEMBL4918477
AKOS025287600
5,7-dihydroxy-2-(3,4,5-trimethoxyphenyl)-4h-chromen-4-one #
CPCPHNWWTJLXKQ-UHFFFAOYSA-N
DTXSID70171059
5-7-dihydroxy-3-4-5-trimethoxyflavone
flavone, 5,7-dihydroxy-3',4',5'-trimethoxy- (8ci)
5,7-dihydroxy-3',4',5'-trimethoxy-flavone
FS-8799
FT-0756628
Q27105170
XD161933
5,7-dihydroxy-3?,4?,5?-trimethoxyflavone
3',4',5'-tri-o-methyl-tricetin
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
trimethoxyflavoneA methoxyflavone that is flavone substituted by three methoxy groups.
dihydroxyflavoneAny hydroxyflavone in which two ring hydrogens are replaced by hydroxy substituents.
3',5'-dimethoxyflavoneA dimethoxyflavone in which the hydroxy groups at positions 3' and 5' have been replaced by methoxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID403036Cytotoxicity against human NCI-H460 cells at 58 uM2005Journal of natural products, Aug, Volume: 68, Issue:8
Constituents of Vittaria anguste-elongata and their biological activities.
AID404069In vivo antitumor activity against mouse L1210 cells
AID403037Cytotoxicity against human SF268 cells at 58 uM2005Journal of natural products, Aug, Volume: 68, Issue:8
Constituents of Vittaria anguste-elongata and their biological activities.
AID400607Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression at 10 uM after 18 hrs measured as microunits of tissue factor/10'5 cells1996Journal of natural products, Mar, Volume: 59, Issue:3
Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes.
AID356482Antihistaminic activity in rat RBL2H3 cells assessed as inhibition of DNP-BSA-induced beta-hexosaminidase release preincubated for 10 mins before DNP-BSA challenge2003Journal of natural products, Sep, Volume: 66, Issue:9
Tricin from a malagasy connaraceous plant with potent antihistaminic activity.
AID356483Cytotoxicity against rat RBL2H3 cells at 500 uM by optical microscope2003Journal of natural products, Sep, Volume: 66, Issue:9
Tricin from a malagasy connaraceous plant with potent antihistaminic activity.
AID1434690Inhibition of sucrose loaded POPC/POPE/POPS/PtdIns(3,4,5)P3 (59:20:20:1) liposome binding to eGFP-fused PDK1 PH domain (unknown origin) expressed in Escherichia coli BL21 at 20 uM after 10 mins by fluorescence spectrophotometry based pull down assay relat2017Bioorganic & medicinal chemistry letters, 02-01, Volume: 27, Issue:3
Inhibitory potential of flavonoids on PtdIns(3,4,5)P3 binding with the phosphoinositide-dependent kinase 1 pleckstrin homology domain.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's3 (42.86)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.70 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.90 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]